Aardvark therapeutics to join prader-willi syndrome community at the 2025 united in hope conference

San diego, june 24, 2025 (globe newswire) -- aardvark therapeutics, inc. (aardvark) (nasdaq: aard), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced that members of its team will join the prader-willi syndrome (pws) community at the 2025 united in hope conference, taking place june 24 to 28 in phoenix, arizona.
AARD Ratings Summary
AARD Quant Ranking